πŸ‡ΊπŸ‡Έ FDA
Patent

US 9770469

Methods of reprogramming renal cells

granted A61KA61K35/22A61P

Quick answer

US patent 9770469 (Methods of reprogramming renal cells) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K35/22, A61P, A61P13/12